Shixia Wang DVM Ph D
About
Shixia Wang DVM Ph D is from Worcester, Massachusetts, United States. Shixia works in the following industries: "Research Services". Shixia is currently Chief Scientific Officer at Conigen Bioscience, Inc., located in Worcester, MA. In Shixia's previous role as a Senior Director of Immunology at Vaxxinity, Shixia worked in until May 2023. Prior to joining Vaxxinity, Shixia was a Scientific Director at Worcester HIV Vaccine and held the position of Scientific Director at Worcester, MA. Prior to that, Shixia was a Professor at University of Massachusetts Medical School, based in United States from Jun 2015 to Aug 2021. Shixia started working as Associate Professor at UMass Medical School in United States in Jan 2009.
Shixia Wang DVM Ph D can be found on Finalscout.com, where members can access Shixia Wang DVM Ph D's email for free. Finalscout is a professional database with more than 500 million business professional profiles and 200 million company profiles.
Shixia Wang DVM Ph D's current jobs
Conigen Bioscience Inc. is a science-driven life science tools company that integrates state-of-art immunology, virology, molecular biology and cell biology to create new reagents and high-quality assays, for a broad range of novel targets to enable new drug modalities, from discovery to development to manufacturing. Dr. Shixia Wang is a Co-Founder and the Chief Scientific Officer of Conigen Bioscience, Inc. Previously, Dr. Wang was a professor at University of Massachusetts Medical School, focused on vaccine and antibody research and discovery since 2000. After 2021, as the senior director of immunology in a vaccine company, she successfully enhanced the team and capabilities, built a state-of-art immunology lab from scratch in a record time. Dr. Wang has extensive knowledge and expertise in vaccinology, immunology, infectious disease, virology, microbiology and antibody research. Her rich experiences cover immunogen design, modern immunological and virological assays, bioanalytical and GLP assay development and management, toxicology and clinical study design, process development for DNA and protein vaccine GMP manufacturing and PreIND/IND filing. Dr. Wang has published over 160 peer-reviewed papers and holds 12 patents.